
RhumbLine Advisers’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.7M | Sell |
186,471
-14,930
| -7% | -$1.1M | 0.01% | 916 |
|
2025
Q1 | $23M | Buy |
201,401
+565
| +0.3% | +$64.5K | 0.02% | 620 |
|
2024
Q4 | $10.1M | Sell |
200,836
-1,996
| -1% | -$101K | 0.01% | 1051 |
|
2024
Q3 | $9.39M | Buy |
202,832
+44
| +0% | +$2.04K | 0.01% | 1096 |
|
2024
Q2 | $6.59M | Sell |
202,788
-3,956
| -2% | -$129K | 0.01% | 1242 |
|
2024
Q1 | $5.21M | Sell |
206,744
-5,549
| -3% | -$140K | 0.01% | 1400 |
|
2023
Q4 | $6.9M | Buy |
212,293
+7,035
| +3% | +$228K | 0.01% | 1232 |
|
2023
Q3 | $5.59M | Buy |
205,258
+454
| +0.2% | +$12.4K | 0.01% | 1276 |
|
2023
Q2 | $4.56M | Sell |
204,804
-5,980
| -3% | -$133K | 0.01% | 1432 |
|
2023
Q1 | $4.57M | Buy |
210,784
+12,976
| +7% | +$281K | 0.01% | 1381 |
|
2022
Q4 | $4.02M | Buy |
197,808
+1,054
| +0.5% | +$21.4K | 0.01% | 1404 |
|
2022
Q3 | $5.05M | Buy |
196,754
+9,881
| +5% | +$253K | 0.01% | 1220 |
|
2022
Q2 | $4.44M | Buy |
186,873
+5,417
| +3% | +$129K | 0.01% | 1303 |
|
2022
Q1 | $4.09M | Buy |
181,456
+2,895
| +2% | +$65.2K | 0.01% | 1442 |
|
2021
Q4 | $3.54M | Sell |
178,561
-1,064
| -0.6% | -$21.1K | ﹤0.01% | 1567 |
|
2021
Q3 | $3.54M | Sell |
179,625
-39,987
| -18% | -$787K | ﹤0.01% | 1566 |
|
2021
Q2 | $4.83M | Sell |
219,612
-3,832
| -2% | -$84.3K | 0.01% | 1446 |
|
2021
Q1 | $5.32M | Buy |
223,444
+5,534
| +3% | +$132K | 0.01% | 1371 |
|
2020
Q4 | $5.7M | Buy |
217,910
+63
| +0% | +$1.65K | 0.01% | 1282 |
|
2020
Q3 | $3.79M | Sell |
217,847
-22,385
| -9% | -$390K | 0.01% | 1324 |
|
2020
Q2 | $4.04M | Sell |
240,232
-13,891
| -5% | -$234K | 0.01% | 1331 |
|
2020
Q1 | $3.02M | Buy |
254,123
+2,100
| +0.8% | +$25K | 0.01% | 1323 |
|
2019
Q4 | $3.05M | Buy |
252,023
+19,240
| +8% | +$233K | 0.01% | 1556 |
|
2019
Q3 | $3.29M | Buy |
232,783
+179
| +0.1% | +$2.53K | 0.01% | 1428 |
|
2019
Q2 | $2.59M | Buy |
232,604
+4,416
| +2% | +$49.2K | ﹤0.01% | 1581 |
|
2019
Q1 | $2.68M | Sell |
228,188
-2,778
| -1% | -$32.6K | 0.01% | 1540 |
|
2018
Q4 | $3.09M | Buy |
230,966
+46,944
| +26% | +$627K | 0.01% | 1386 |
|
2018
Q3 | $2.58M | Buy |
184,022
+775
| +0.4% | +$10.9K | 0.01% | 1521 |
|
2018
Q2 | $2.88M | Buy |
183,247
+11,790
| +7% | +$185K | 0.01% | 1468 |
|
2018
Q1 | $2.82M | Buy |
171,457
+3,400
| +2% | +$55.9K | 0.01% | 1404 |
|
2017
Q4 | $3.04M | Buy |
168,057
+78,700
| +88% | +$1.42M | 0.01% | 1374 |
|
2017
Q3 | $1.73M | Buy |
89,357
+1,685
| +2% | +$32.5K | ﹤0.01% | 1700 |
|
2017
Q2 | $1.04M | Buy |
87,672
+15,494
| +21% | +$183K | ﹤0.01% | 1940 |
|
2017
Q1 | $791K | Buy |
72,178
+2,492
| +4% | +$27.3K | ﹤0.01% | 2031 |
|
2016
Q4 | $506K | Buy |
69,686
+9,684
| +16% | +$70.3K | ﹤0.01% | 2222 |
|
2016
Q3 | $390K | Buy |
60,002
+3,139
| +6% | +$20.4K | ﹤0.01% | 2347 |
|
2016
Q2 | $310K | Buy |
56,863
+8,272
| +17% | +$45.1K | ﹤0.01% | 2510 |
|
2016
Q1 | $227K | Sell |
48,591
-40
| -0.1% | -$187 | ﹤0.01% | 2674 |
|
2015
Q4 | $242K | Buy |
48,631
+4,855
| +11% | +$24.2K | ﹤0.01% | 2692 |
|
2015
Q3 | $165K | Buy |
43,776
+1,951
| +5% | +$7.35K | ﹤0.01% | 2853 |
|
2015
Q2 | $251K | Sell |
41,825
-1,650
| -4% | -$9.9K | ﹤0.01% | 2763 |
|
2015
Q1 | $243K | Buy |
43,475
+10,100
| +30% | +$56.5K | ﹤0.01% | 2729 |
|
2014
Q4 | $100K | Sell |
33,375
-8,510
| -20% | -$25.5K | ﹤0.01% | 2961 |
|
2014
Q3 | $112K | Hold |
41,885
| – | – | ﹤0.01% | 2913 |
|
2014
Q2 | $117K | Sell |
41,885
-1,620
| -4% | -$4.53K | ﹤0.01% | 2954 |
|
2014
Q1 | $190K | Sell |
43,505
-2,600
| -6% | -$11.4K | ﹤0.01% | 2787 |
|
2013
Q4 | $148K | Sell |
46,105
-200
| -0.4% | -$642 | ﹤0.01% | 2904 |
|
2013
Q3 | $74K | Sell |
46,305
-491
| -1% | -$785 | ﹤0.01% | 2955 |
|
2013
Q2 | $81K | Buy |
+46,796
| New | +$81K | ﹤0.01% | 3272 |
|